62 results about "Transfection vector" patented technology

The present invention relates to a novel secretory signal, a novel plasmid containing the secretory signal, a transformed anaerobic bacterium transformed with said plasmid, a gene transfer carrier consisting of said anaerobic bacterium, and a pharmaceutical composition containing said carrier.

The invention discloses a preparation method and an application of a hydroxyl-containing crosslinked polymer and guanidinated product thereof used for delivering nucleic acid and other bioactive agents. The method comprises the specific steps that: linear or branched polyethyleneimine with a molecular weight of 100-30000Da or various multi-amine compounds are subjected to a compounding reaction with one or more crosslinking agents with a molecular weight of 100-5000Da and containing two or more epoxy groups, such that the hydroxyl-containing crosslinked polymer is prepared. The invention also provides a synthesizing method of a novel guanidination reagent 3-guanidino propanol acrylate or 5-guanidino amyl acrylate. With the guanidination reagent, the hydroxyl-containing crosslinked polymer or other polymers can be guanidinated, such that gene transfection efficiency thereof can be substantially improved, and cytotoxicity can be reduced. The excellent-performance polymers screened by the invention have gene transfection efficiencies in various cell lines such as A549, B16F10, 3T3, and U87 substantially higher than conventional commercialized gene transfection reagents. The polymers are low-toxic high-efficiency non-virus gene transfection vectors. With the vectors provided by the invention, in-vitro high-efficiency and low-toxicity transfection of various cells can be realized, and in-vivo high-efficiency and low-toxicity local administration can be realized. The application has wide application prospect.

The present invention relates to a novel secretory signal, a novel plasmid containing the secretory signal, a transformed anaerobic bacterium transformed with said plasmid, a gene transfer carrier consisting of said anaerobic bacterium, and a pharmaceutical composition containing said carrier.

The invention relates to the field of polymer modification, and in particular to a modified polyethyleneimine and application thereof in the preparation of a gene transfection vector reagent. According to the present invention, hydrophobic rosin acid or dehydroabietic acid is grafted onto polyethyleneimine to obtain the modified polyethyleneimine. The hydrophobic group of the modified polyethyleneimine forms a dense hydrophobic core with strong hydrophobicity due to the intermolecular forces in water, hydrophilic polyethyleneimine forms hydrophilic shell, thereby forming a nano micelles with shell-core structure, and nanoparticles with small particle size formed after DNA binding. The composite nanoparticles in smaller size gains tighter structure, so that composite nanoparticles are easier to pass through the cell membrane structure of a lipid bilayer, and the efficiency of transfection is improved. The modified polyethyleneimine can be applied to the preparation of gene transfection vectors and has the characteristics of high biological safety, high transfection efficiency, and low cost.

The present invention relates to a novel secretory signal, a novel plasmid containing the secretory signal, a transformed anaerobic bacterium transformed with said plasmid, a gene transfer carrier consisting of said anaerobic bacterium, and a pharmaceutical composition containing said carrier.

The invention discloses applications of arabidopsis thaliana JAV1 protein and a coding gene of arabidopsis thaliana JAV1 protein in regulation of plant disease resistance and insect resistance. The invention also provides a method used for improving plant disease resistance and insect resistance, short hairpin RNA capable of reducing JAV1 gene expression material content, small interfering RNA, an interference vector, and interference segments. It is confirmed by experiments that, compared with wild type and null-transfection vector control groups, relative expression level of T3 generation pBI121-JAV1-RNAi transfected arabidopsis thaliana is reduced significantly, leaf infected area is 0.25 to 0.27cm<2> after inoculation by botrytis cinerea, and is obviously smaller than that of wild type and null-transfection vector control groups; the weight of beet armyworm larvae which are fed with leaves of 5 weeks for 6 days increases 1.58 to 2.03mg, and is obviously lower than that of wild type and null-transfection vector control groups; and plants are capable of growing normally in 12 days when bradysia odoriphaga larvae are put into soil with the plants of 18 days. According to the applications of arabidopsis thaliana JAV1 protein and the coding gene of arabidopsis thaliana JAV1 protein, a novel approach is provided for cultivation of disease-resistant and insect-resistant plants, and in the field of agricultural production, application range is wide, and market prospect is promising.

The invention belongs to the technical field of biological medicines and aims at improving the gene transfection efficiency by adopting nano-particles NoNPs released through cells. The nano-particles exist extensively in a biosystem and an extracellular circulatory system, such as bronchoalveolar lavage fluid, body fluid, blood, saliva, cow milk or urine. A non-virus gene transfection vector is doped with the nano-particles so that the DNA (Desoxvribose Nucleic Acid) carrying capacity of the gene transfection vector can be improved remarkably without increase of cytotoxicity. Experimental results indicate that the NONPs, which are extracted from the cow milk and added to the PEI gene transfection vector, are capable of remarkably improving the gene transfection efficiency under the circumstance of hardly increasing the cytotoxicity. The major use of the nano-particles is to serve as the gene transfection reagent which can be used for cell biology research, gene transfection preparation production, gene therapy and the like.

The invention relates to a method for preparing a lipidosome/gel composite gene activation scaffold, belonging to the technical field of biomedicine. The method disclosed by the invention comprises the following steps: taking TAT modified liposome as a high-efficiency gene transfection vector, entrapping the vector into MMPs sensitive peptide cross-linked hyaluronic acid gel, and constructing theMMPs-sensitive gene activation scaffold in which the lipidosome is entrapped. The MMPs can be secreted by cells in the migration and proliferation process, so that the gel is degraded. On the one hand, a space is created for migration and proliferation of the cells, and a meshed structure of the gel is prevented from becoming a physical barrier of cell migration and proliferation; on the other hand, the TAT-liposome is released, and peripheral cells are subjected to high-efficiency in-situ transfection, so that growth factors are expressed and secreted, and tissue repair and regeneration can be promoted.

The invention provides a fluorine-nitrogen doped carbon quantum dot prepared from a fluorine-containing aromatic compound and a cationic polymer. The fluorine-containing aromatic compound is linked tothe cationic polymer through a covalent bond; and the cationic polymer is linear polyethyleneimine or branched polyethyleneimine. The invention also provides a preparation method of the fluorine-nitrogen doped carbon quantum dot and application of the fluorine-nitrogen doped carbon quantum dot as a gene delivery vector. The preparation method provided by the invention adopts a hot solvent to prepare the fluorine-nitrogen doped carbon quantum dot with a one-pot method, is simple in reaction, low in preparation cost, available in raw material and high in yield, can reach the efficient transfection effect in the cell transfection process, is relatively small in toxicity produced to cells in the transfection process, can effectively and safely deliver gene molecules into the cells and is a gene transfection vector which has the advantages of high efficiency, low toxicity, low cost, simpleness and easiness in synthesis and the like.

The invention provides a gene editing system for preparing allotransplantable T cells. The system is characterized by comprising sgRNA, wherein the sgRNA in a CRISPR/Cas9 specific knockout human TCR gene is used for specifically targeting a TCR gene. The target sequence of the sgRNA on the TCR gene conforms to a sequence arrangement rule of 5'-G(21N)NNGRRT-3 or 5'-ARRCNN(21N)C-3', the target sequence of the targeted knockout TCR gene takes virus as a transfection vector, and a chimeric antigen receptor gene with TCR gene homologous arms at the 5' end and the 3' end can transfect cells togetherwith the virus containing the target sequence of the TCR gene by using the virus as a vector when in use, or packs the target sequence of the TCR gene, Cas9 and the chimeric antigen receptor gene with the TCR gene homologous arms at the 5' end and the 3' end together in baculovirus and transfects cells with the baculovirus as a vector.

The invention relates to the technical field of biology, and discloses dopamine functionalized poly(beta-amino ester) as well as a preparation method and application thereof. The structural formula of the poly(beta-amino ester) is shown in the specification, and the preparation method of the poly(beta-amino ester) comprises the steps: carrying out a polymerization reaction on 1,4-butanediol diacrylate and an amino-containing monomer; carrying out end capping on the polymer by adopting small molecular amine; and finally, carrying out deprotection on the phenolic hydroxyl group of dopamine to obtain the dopamine functionalized poly(beta-amino ester). Dopamine is introduced into PBAE, and ferric ions are complexed with the PBAE to form an encapsulated nanoparticle structure, so that the stability of a compound is improved, and a gene transfection vector with high transfection efficiency and low cytotoxicity is obtained, so that the gene transfection vector has potential clinical application value in the aspect of non-viral gene vectors.

The invention provides a method for improving the calcium and phosphorus utilization ratio of livestock and poultry. The method comprises the following steps: (1) obtaining full-length DNA of a phytase gene; (2) preparing a coccidium transfection vector pMDEA-phytase; (3) performing transfection on the vector and screening transgenic coccidia; and (4) inoculating the transgenic coccidia for expressing phytase into bodies of the livestock and poultry in an oral administration manner to ensure that the coccidia express and release phytase while developing in intestinal tracts, and degrading phytic acid. By adopting the method provided by the invention, phytase genes with different sources are expressed in the coccidia for the first time, so that a recombinant micro biological reactor is obtained and can generate phytase directly applied to the livestock and poultry, and equipment for production and purification and related operations are not needed.

The invention provides a gene transfection vector based on a dendrimer skeleton and a nucleic acid basic group as shown in a formula (1). The gene transfection vector comprises a dendrimer and a nucleic acid base derivative, wherein the nucleic acid base derivative is in covalent linkage with the surface of the dendrimer. The invention also provides a preparation method of the gene transfection vector shown in the formula (1) and application as a nucleic acid molecule delivery vector. The gene transfection vector provided by the invention is low in synthesis cost and small in cell toxicity, can effectively and safely convey genetic molecules into cells, can be used as the gene transfection vector with the advantages of high efficiency, low toxicity, low cost and the like, and has good application prospect.

A Perkinsus heterologous expression system that is useful to produce recombinant proteins, e.g., from related parasites of medical and veterinary relevance. This expression system increases the number of genes that can be targeted for protein structure/function studies, production of antigens, and in vitro drug screening. Also described is a transfection system for Perkinsus species, including a transfection vector expressing heterologous DNA encoding one or more Apicomplexa proteins.

The invention relates to a non-genetically modified light control bidirectional regulation method for human umbilical cord mesenchymal stem cell proliferation. The method includes the steps: irradiating human umbilical cord mesenchymal stem cells at 95-105mm positions under a collimating mirror for 85-95min through the collimating mirror by the aid of blue light under the conditions of the light wavelength of 400-480nm and the light intensity of 95-105 micro-w/cm<2>, and performing negative regulation; or irradiating the human umbilical cord mesenchymal stem cells at the 95-105mm positions under the collimating mirror for 115-125min through the collimating mirror by the aid of blue light, and performing positive regulation. According to the method, the multiplication speed of the human umbilical cord mesenchymal stem cells is firstly and bi-directionally regulated only through blue light irradiation under setting of special parameters, foreign genes transferred into the stem cells areomitted, virus transfection vectors are omitted, any other substances are omitted, and the method more meets clinical application requirements of 'noninvasive light therapy' and has a wide clinical application prospect.

The invention discloses a construction method of fusarium graminearum single-stranded circular DNA (Deoxyribonucleic Acid) virus FgGMTV1/HB58 infectious cloning. A virus genome contains two single-stranded circular DNA molecules including DNA-A and DNA-B, and genome sequences of the DNA-A and the DNA-B are shown as SEQ ID NO: 1 to 2; the virus genome does not contain a single-stranded circular DNAmolecule DNA-C and the genome sequence of the DNA-C is shown as SED ID NO: 3. The construction method comprises the following steps: constructing DNA-A infectious cloning, constructing DNA-B infectious cloning and constructing DNA-C infectious cloning. When the infectious cloning is constructed, only one bacterium cloning vector pBluescript II SK(+) is needed and fungi can be cloned and transfected successfully; cloning and transfection steps are simplified and a plurality of times of PCR (Polymerase Chain Reaction) cloning are not needed; a plurality of cloning vectors and transfection vectors are not needed, and the transfection can be finished, without the need of cloning the fungi to a binary expression vector.

The invention provides a purification method for a recombinant human antibody fusion protein. The method comprises the following steps: (a) providing a transfection vector for expressing a gene of therecombinant human antibody fusion protein; (b) transfecting the transfection vector into a mammalian cell and performing culturing to obtain a raw material solution containing the recombinant human antibody fusion protein and impurities; (c) carrying out affinity chromatography on the raw material solution to obtain an affinity chromatography solution; and (d) carrying out low-pH incubation and deep filtration on the affinity chromatography solution to prepare a first purified solution, namely the purified recombinant human antibody fusion protein, wherein the pH value of the low-pH incubation is 3-4, and citric acid or salt thereof is utilized to adjust the pH value. The method disclosed by the invention not only can remove the impurities efficiently, but also keeps the activity of the target protein-the recombinant human antibody fusion protein, so that the high-purity and high-concentration recombinant human antibody fusion protein is prepared so as to be used for treating ocular neovascularization diseases of mammals.

Disclosed herein are expression vectors suitable for transfection in amoebas. The vectors may include a promoter from a protein-encoding gene from an amoeba, a selection marker, and a polynucleotide sequence encoding a polypeptide of interest, operably linked to the promoter. The promoter may be from the ACT1 gene from Naegleria fowleri.

The present invention provides a dendrimer transgene carrier modified with bone-targeting peptide and naphthalimide, which includes a dendrimer skeleton, a bone-targeting peptide group, and a functional group containing naphthalimide. The targeting peptide group and the naphthalimide functional group are covalently bonded on the surface of the dendrimer; the dendrimer is a polyamide-amine dendrimer. The invention also provides the preparation method of the gene transfection carrier and the application of the dendrimer transgene carrier as a nucleic acid molecule delivery carrier. The invention adopts a brand-new modification method and a functional group to modify the dendrimer, the reaction is simple and efficient, the yield is high, the efficient transfection effect is achieved in the cell transfection process, and the bone targeting performance is better. The production of materials is simple and low in cost, the cytotoxicity of the transfection process is low, and gene molecules can be effectively and safely transported into cells. The dendrimer transgene carrier of the present invention has the advantages of high efficiency, low toxicity, low price, and simple synthesis .